|Articles|June 1, 2005
- Pharmaceutical Technology-06-01-2005
- Volume 205 Supplement
- Issue 3
The Part 11 Controversy: A Root Cause Analysis and Science-Based Solutions
The confusion surrounding the application of 21 CFR Part 11 can be solved by focusing on the common rationale that both protects the public health and drives the fundamental basis of the industry's business: good science.
Advertisement
Articles in this issue
about 21 years ago
Electronic Records Management Practices and Part 11about 21 years ago
Applying Part 11 to the Implementation of Quality Management Softwareabout 21 years ago
Glossary of termsabout 21 years ago
Electronic Records Management Practices and Part 11Tamar M. Juneabout 21 years ago
21 CFR 11 Overview of the Final Document and its New Scope Ludwig HuberAdvertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
2
The Next Generation of Medicine: Personalized, Preventive, and Powered by Technology
3
What FDA's AI Warning Letter Tells Us About GMP Accountability
4
Regulatory Actions Impacting Biologics
5